Director/PDMR Shareholding

AdvancedAdvT Limited
24 May 2024
 

24 May 2024

 

AdvancedAdvT Limited

 

PDMR Dealings

 

AdvancedAdvT Limited (AIM: ADVT, "AdvT", "the Group"), the international software solutions provider for the business solutions, healthcare compliance, and human capital management sectors has been notified that on 23 May 2024 Barbara Firth, Non-Executive Director and Senior Independent Director, purchased 70,000 ordinary shares of no par value ("Ordinary Shares") at a price of £1.41 per Ordinary Share.

 

Following the completion of the transaction, Barbara Firth's total beneficial interest in the Company stands at 70,000 Ordinary Shares, representing 0.05% of the total issued share capital.

 

Details of the transaction can be found in the Notification of Dealing Form below.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Barbara Firth

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director and Senior Independent Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

AdvancedAdvT Limited

b)

 

LEI

 

 

254900WYO35S1T334A28

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of no par value fully paid (DI)



Identification code

VGG0103J1075



b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




£1.41

70,000







d)

 

Aggregated information




- Aggregated volume

n/a



- Price

n/a



e)

 

Date of the transaction

 

 

23 May 2024

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (XLON)

 

 

Enquiries:

 

AdvancedAdvT Limited


Vin Murria, Chairperson

Gavin Hugill, Chief Financial Officer

c/o Meare Consulting



Singer Capital Markets (Nominated Adviser and Broker)

Tel: 020 7496 3000

Philip Davies / Asha Chotai / Sam Butcher




KK Advisory (Investor Relations)

Tel: 020 7039 1901

Kam Bansil 


 

Meare Consulting 


Adrian Duffield

Tel: 07990 858548

 

Note to Editors

 

AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.

The Group's operations are IBSS (financial management software), CHKS (AI based healthcare intelligence compliance and accreditation software), Retain (global resource planning and talent management software) and WFM (workforce management software provider).

AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in these sectors where long term digitisation trends are set to transform the workplace for professionals. 

AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings